Preparation method for nanoparticle pharmaceutical composition, and nanoparticle pharmaceutical composition
A nanoparticle and composition technology, applied in the field of nanoparticle medicine, can solve the problem of difficult control of the content ratio of drug compounds
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0021] The invention provides a method for preparing a nanoparticle pharmaceutical composition, the nanoparticle pharmaceutical composition contains amphiphilic polymers, cationic polymers, hydrophobic drugs, hydrophilic small molecule drugs and nucleic acid drugs, the method comprising The following steps:
[0022] (1) Under the condition of ultrasonic radiation, the first solution is mixed and emulsified with the aqueous solution of the hydrophilic small molecule drug to obtain the first emulsion;
[0023] The first solution contains the amphiphilic polymer and a first organic solvent; the first organic solvent is capable of dissolving the amphiphilic polymer, but is insoluble in water, and does not mix with the described amphiphilic polymer under emulsifying conditions. an organic solvent for the chemical reaction of the amphiphilic polymer, the hydrophobic drug, the hydrophilic small molecule drug and the nucleic acid drug;
[0024] (2) mixing the first emulsion with the ...
Embodiment 1
[0071] In this example, the nanoparticle pharmaceutical composition was prepared according to the following steps.
[0072] (1) 20 mg of amphiphilic polymer (polyethylene glycol monomethyl ether-polylactic acid-glycolic acid, PLGA-PEG, purchased from Jinan Daigang Biotechnology Co., Ltd., the polyethylene glycol monomethyl ether-poly The hydrophilic group of the lactic acid-glycolic acid copolymer is a polyethylene glycol monomethyl ether group, and the hydrophobic group is a polylactic acid-glycolic acid group, and the polyethylene glycol monomethyl ether-polylactic acid-glycolic acid copolymerization The arrangement of the repeating units of the compound is a block, wherein the molar ratio between the ethylene glycol unit and the lactic acid-glycolic acid unit is 1:1-1:8, and the weight average measured according to the method specified in SHT 1759-2007 Molecular weight is 10 4 -1.5×10 5 ) was dissolved in 1 ml of the first organic solvent (dichloromethane) to obtain the f...
Embodiment 2
[0090] In this example, the nanoparticle pharmaceutical composition is prepared according to the method of Example 1, the difference is that the concentration of doxorubicin in the aqueous solution of the hydrophilic small molecule drug is 0.4 mg / ml, and the concentration of paclitaxel in the second solution is The concentration of the nucleic acid drug is 10 mg / ml, and the dosage of the nucleic acid drug is 0.05 mg.
[0091] According to the same measurement method as in Example 1, the particle size of the nanoparticle pharmaceutical composition obtained in this embodiment is measured by a laser particle size analyzer to be about 200nm; The content of mycin was 0.0005 g, the content of paclitaxel was 0.5 g, and the content of siRNA was 0.000045 g.
PUM
| Property | Measurement | Unit |
|---|---|---|
| Viscosity | aaaaa | aaaaa |
| Particle size | aaaaa | aaaaa |
| Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
